Skip to main content

Table 13 Comparisons of the selectivity index (SI) of antiviral activity on HSV-1 between prophylactic (IVR) and virucidal (DVI) at best time for MBS extract and between that of MBS extract and the standard drug (Acyclovir)

From: Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus −1: an in vitro study on virally infected Vero and MRC-5 cell lines

Extract Protocol vs Protocol Time vs Time SI vs SI P value  
MBS aIVR vs bDVI 1 h vs 2 h 10.9 ± 0.96 vs 18.23 ± 1.69 0.009 Significant
MBS vs Acyclovir aIVR vs aIVR 1 h vs 1 h 10.9 ± 0.96 vs 15.04 ± 1.9 0.06 Non-significant
MBS vs Acyclovir bDVI vs bDVI 2 h vs 2 h 18.23 ± 1.69 vs 22.56 ± 1.11 0.05 Non- Significant
  1. Note: aIVR: the inhibition in virus infection after specific cell treatment. bDVI: the direct virus inactivation